# Results Summary: DASS Predict Memory Performance

**Research Question:** Do depression, anxiety, or stress (DASS-21 subscales) predict REMEMVR episodic memory accuracy?

**Analysis Completed:** 2026-01-06

**Analyst:** rq_results agent (v4.0) with master claude orchestration

---

## 1. Statistical Findings

### Sample Characteristics
- Total N: 97 participants with complete DASS and memory data
- Missing data: Minimal (complete cases analysis)
- Exclusions: Participants without complete DASS-21 subscale scores
- Age: M = 44.8 years (SD = 14.7, range 18-85)

### Primary Results

**Hierarchical Regression Models:**
- Model 1 (Controls): R² = 0.059, F(2, 94) = 2.97, p = 0.056
  - Controls: Age + NART score
- Model 2 (Full Model): R² = 0.091, F(5, 91) = 1.83, p = 0.115
  - Full model: Controls + DASS subscales (Depression, Anxiety, Stress)

**Incremental Variance Test:**
- ”R² = 0.032 (3.2% additional variance from DASS predictors)
- F(3, 91) = 1.07, p = 0.367 (NOT SIGNIFICANT)
- Bootstrap 95% CI for ”R²: [0.004, 0.168]

**Individual DASS Predictor Effects:**

| Predictor | ² | SE | t | p (uncorr) | p (Bonf) | 95% CI |
|-----------|---|----|----|------------|----------|---------|
| DASS_Dep | -0.021 | 0.026 | -0.82 | 0.416 | 1.000 | [-0.072, 0.030] |
| DASS_Anx | 0.043 | 0.040 | 1.08 | 0.282 | 0.846 | [-0.036, 0.122] |
| DASS_Str | 0.014 | 0.031 | 0.44 | 0.662 | 1.000 | [-0.047, 0.075] |

### Cross-Reference to plan.md
Outputs matched expectations: N H 97, dual p-value reporting implemented (Decision D068), hierarchical regression completed with cross-validation and power analysis. All substance criteria met.

---

## 2. Plot Descriptions

### Figure 1: Hierarchical Model Comparison
**File:** model_comparison.png

**Visual Description:**
Bar chart comparing R-squared values between Model 1 (controls only) and Model 2 (controls + DASS predictors). Model 1 shows R² H 0.059, Model 2 shows R² H 0.091. The modest increase visually represents the small 3.2% incremental variance contributed by DASS subscales.

**Connection to findings:** Visual confirms the non-significant ”R² = 0.032 - while Model 2 has higher R², the difference is small and statistically non-significant (p = 0.367).

### Figure 2: DASS Predictor Effects
**File:** predictor_effects.png

**Visual Description:**
Bar plot showing standardized beta coefficients for the three DASS predictors with 95% confidence intervals. All three effects cluster around zero:
- Depression: slightly negative (² H -0.02)
- Anxiety: slightly positive (² H +0.04) 
- Stress: near zero (² H +0.01)

All confidence intervals cross zero, indicating non-significance. Error bars are relatively wide compared to effect sizes, suggesting low precision.

**Connection to findings:** Visual confirms statistical null findings - all DASS effects are trivially small with confidence intervals including zero, consistent with p-values > 0.28.

### Figure 3: Regression Diagnostics
**File:** regression_diagnostics.png

**Visual Description:**
Four-panel diagnostic plot:
- **Residuals vs Fitted:** Random scatter around zero with no systematic patterns (homoscedasticity confirmed)
- **Normal Q-Q Plot:** Points follow diagonal line reasonably well (residual normality acceptable)
- **Scale-Location:** Consistent spread across fitted values
- **Cook's Distance:** No points exceed threshold (no influential outliers)

**Connection to findings:** Diagnostics support model validity - assumptions met, no problematic influential points, residuals behave appropriately for regression analysis.

### Figure 4: Memory Distribution by Depression Level
**File:** memory_distribution.png

**Visual Description:**
Overlapping histograms comparing theta_all memory scores between low and high depression groups. Distributions largely overlap with similar central tendencies, consistent with the negligible depression effect (² = -0.021). Both groups show normal-like distributions centered near zero.

**Connection to findings:** Visual supports statistical finding of no meaningful depression-memory relationship - distributions nearly identical between depression levels.

---

## 3. Interpretation

### Hypothesis Testing

**Original Hypothesis (from 1_concept.md):**
"Small negative effects expected for all three DASS subscales predicting REMEMVR accuracy, with depression showing the strongest effect due to encoding motivation impairment."

**Hypothesis Status:** **NOT SUPPORTED**

The statistical findings contradict the hypothesis:
- No significant incremental variance from DASS predictors (”R² = 0.032, p = 0.367)
- Individual effects trivially small and non-significant (all p > 0.28)
- Depression did not show strongest effect (² = -0.021, weakest among predictors)

### Theoretical Contextualization

**Null Findings Interpretation:**

The absence of DASS-memory relationships in this sample can be understood through several theoretical lenses:

1. **Subclinical Sample Effect:**
   - DASS scores predominantly in normal/mild ranges (M_dep = 2.39, M_anx = 1.47, M_str = 3.43)
   - Clinical thresholds: Depression e 10, Anxiety e 8, Stress e 15
   - Cognitive-emotional theories predict effects primarily in clinical/high-distress populations

2. **Cognitive Reserve Compensation:**
   - Sample included cognitively healthy adults (NART controlled)
   - Mild psychological distress may not overcome cognitive reserve in demanding VR episodic memory tasks
   - Compensation mechanisms may mask subtle distress effects

3. **VR Task Specificity:**
   - Immersive VR may engage different neural systems than traditional memory paradigms
   - Spatial navigation strengths may compensate for distress-related encoding vulnerabilities
   - Task engagement and novelty may override mood-congruent memory effects

### Domain-Specific Insights

**Episodic Memory in VR Context:**
- REMEMVR theta_all scores aggregate across What/Where/When domains
- Null DASS effects suggest psychological distress does not differentially impair multi-domain episodic memory in immersive virtual environments
- Contrasts with laboratory findings using simpler memory tasks in clinical samples

**Individual Differences Perspective:**
- Large individual differences in forgetting trajectories (from Ch7 context) may overshadow small distress effects
- Age and cognitive ability (NART) explain more memory variance than psychological symptoms
- Suggests robust VR episodic memory assessment resistant to mood state influences

### Unexpected Patterns

**Positive Anxiety and Stress Effects:**
Contrary to predictions, anxiety (² = +0.043) and stress (² = +0.014) showed small positive relationships with memory. Possible explanations:
1. **Optimal Arousal:** Mild anxiety may enhance attention and encoding via Yerkes-Dodson law
2. **Measurement Artifact:** Subclinical anxiety reflecting arousal/engagement rather than dysfunction
3. **Sample Characteristics:** Healthy adults may interpret "stress" as adaptive challenge rather than distress

**Cross-Validation Overfitting:**
Mean test R² = -0.17 vs training R² = 0.10 suggests severe overfitting, indicating model captures noise rather than signal. This supports null interpretation - any apparent effects reflect sample-specific variation.

### Broader Implications

**REMEMVR Validation:**
- VR episodic memory assessment appears robust to subclinical psychological distress
- Supports clinical utility - performance unlikely confounded by mild mood symptoms
- Contrasts with traditional neuropsychological tests more sensitive to anxiety/depression

**Methodological Insights:**
- Extremely conservative Bonferroni correction (± = 0.00060) may be overly stringent for exploratory psychological research
- Small expected effects require much larger samples for adequate power (N > 500 per power analysis)
- Cross-validation revealed overfitting, highlighting importance of external validation

---

## 4. Limitations

### Sample Limitations

**Sample Size and Power:**
- N = 97 provides only 28% power for detecting small psychological effects at ± = 0.05
- Power drops to 1.8% with Bonferroni correction (± = 0.00060)
- Minimum detectable effect f² = 0.259 (large effect) far exceeds realistic psychological effect sizes
- Post-hoc power analysis indicates N > 500 needed for 80% power at corrected alpha

**Sample Characteristics:**
- Predominantly subclinical DASS scores limit generalizability to clinical populations
- Age range 18-85 but cognitive ability controlled (NART) may restrict generalizability
- Healthy volunteer sample may underrepresent individuals with clinically significant distress

**Missing Data:**
- Complete cases analysis (N = 97) excluded participants with missing DASS data
- Potential bias if DASS missingness related to psychological distress levels
- No systematic tracking of exclusion reasons

### Methodological Limitations

**Measurement Issues:**
1. **DASS-21 Specificity:**
   - Designed for clinical populations, may lack sensitivity in healthy samples
   - Floor effects likely in subclinical range
   - State vs trait distinction unclear (recent symptoms vs stable tendencies)

2. **Theta Aggregation:**
   - Uses omnibus theta_all scores rather than domain-specific effects
   - May mask differential distress impacts on What/Where/When domains
   - IRT assumptions (unidimensionality, local independence) limit interpretation

3. **Cross-Sectional Design:**
   - Cannot establish causal relationships
   - Mood-memory interactions may be bidirectional
   - No control for daily mood fluctuations during VR testing

**Statistical Limitations:**
1. **Multiple Comparisons:**
   - Conservative Bonferroni correction reduces power substantially
   - May miss true small effects (Type II error inflation)
   - Alternative corrections (FDR) also yielded null results

2. **Model Specification:**
   - Linear relationships assumed (may miss threshold/non-linear effects)
   - No interaction terms tested (e.g., age × depression)
   - Random effects not modeled (repeated measures within participants)

### Generalizability Constraints

**Population Generalizability:**
- Findings may not extend to:
  - Clinical samples with major depression, anxiety disorders
  - Older adults with age-related cognitive decline
  - Adolescents with developing emotion regulation
  - Non-Western populations (cultural differences in distress expression)

**Task Generalizability:**
- VR desktop paradigm differs from:
  - Real-world episodic memory demands
  - Traditional neuropsychological assessments
  - Clinical memory evaluation contexts

**Context Generalizability:**
- Laboratory setting may not reflect:
  - Naturalistic mood-memory interactions
  - Chronic vs acute psychological distress effects
  - Ecologically valid memory retrieval contexts

### Technical Limitations

**Cross-Validation Overfitting:**
- Severe overfitting (test R² = -0.17) indicates model instability
- Suggests effects are sample-specific noise rather than generalizable signal
- Limits confidence in any observed relationships

**Power Analysis Constraints:**
- Post-hoc power analysis based on observed effects may be biased
- Sensitivity analysis assumes normally distributed effects
- Cohen's conventions for effect sizes may not apply to VR episodic memory

**Decision D068 Implementation:**
- Dual p-value reporting increases analysis complexity without clear benefit for null findings
- Bonferroni correction extremely conservative for exploratory research
- May discourage appropriate follow-up investigations

---

## 5. Next Steps

### Immediate Follow-Ups (Current Data)

**1. Domain-Specific DASS Effects:**
- **Why:** Omnibus theta_all may mask domain-specific relationships
- **How:** Re-analyze using separate What/Where/When theta scores from Ch5 5.1.1
- **Expected Insight:** Depression may specifically impair temporal memory due to reduced cognitive control
- **Timeline:** Immediate (uses available Ch5 domain-specific outputs)

**2. Non-Linear Relationship Testing:**
- **Why:** Linear DASS effects assumed but threshold/quadratic patterns possible
- **How:** Add polynomial terms, spline regression, or threshold models
- **Expected Insight:** Clinical threshold effects may emerge at higher DASS scores
- **Timeline:** 1-2 days (requires model respecification)

**3. Clinical Subsample Analysis:**
- **Why:** Effects may be confined to participants with elevated DASS scores
- **How:** Subset to participants above clinical cutoffs (Depe10, Anxe8, Stre15)
- **Expected Insight:** Clinical-level distress may show meaningful memory relationships
- **Timeline:** Immediate (subset analysis of current data)

### Planned Thesis RQs (Chapter 7 Continuation)

**RQ 7.5.3: Confidence-Accuracy Relationships (Planned):**
- **Focus:** How psychological distress affects metacognitive monitoring
- **Why:** Null DASS-memory effects may coexist with distress-confidence relationships
- **Builds On:** DASS predictors from this RQ + confidence ratings from master.xlsx
- **Expected Timeline:** Next RQ in Ch7 psychological series

**RQ 7.6.X: Clinical Sample Validation (Future):**
- **Focus:** DASS-memory relationships in clinical depression/anxiety samples
- **Why:** Subclinical findings may not generalize to clinical populations
- **Builds On:** REMEMVR paradigm validated in healthy sample
- **Expected Timeline:** Future data collection beyond current thesis

### Methodological Extensions (Future Data Collection)

**1. Increase Sample Size for Small Effect Detection:**
- **Current Limitation:** N=97 underpowered for psychological effect sizes
- **Extension:** Target N=500+ for 80% power at ±=0.00060
- **Expected Insight:** Adequate power to detect clinically meaningful small effects
- **Feasibility:** Requires major data collection expansion (~1-2 years)

**2. Longitudinal Mood-Memory Assessment:**
- **Current Limitation:** Cross-sectional design prevents causal inference
- **Extension:** Repeated DASS + VR memory over 6 months
- **Expected Insight:** Test whether mood changes predict memory trajectory changes
- **Feasibility:** Requires longitudinal study design (~18 months)

**3. Clinical Sample Recruitment:**
- **Current Limitation:** Subclinical DASS scores limit generalizability
- **Extension:** Recruit participants with diagnosed depression/anxiety disorders
- **Expected Insight:** Test whether clinical-level distress impairs VR episodic memory
- **Feasibility:** Requires clinical partnerships and ethical approval (~2 years)

### Theoretical Questions Raised

**1. VR Task Resistance to Mood Effects:**
- **Question:** Why does VR episodic memory appear resistant to psychological distress effects observed with traditional tasks?
- **Next Steps:** Systematic comparison of DASS effects across VR vs 2D memory paradigms
- **Expected Insight:** Identify task features that moderate mood-memory relationships

**2. Domain-Specific Vulnerability Patterns:**
- **Question:** Do specific episodic memory domains (What/Where/When) show differential sensitivity to depression vs anxiety vs stress?
- **Next Steps:** Domain-specific analyses with larger clinical samples
- **Expected Insight:** Targeted interventions for domain-specific distress effects

**3. Subclinical vs Clinical Threshold Effects:**
- **Question:** Are mood-memory relationships linear or does clinical threshold emergence create discontinuous effects?
- **Next Steps:** Mixed clinical-healthy samples with threshold modeling
- **Expected Insight:** Inform clinical cutoffs for VR memory assessment validity

### Priority Ranking

**High Priority (Do First):**
1. Domain-specific DASS analysis - tests whether omnibus theta masking domain effects
2. Clinical subsample analysis - tests threshold hypothesis with available data
3. Non-linear relationship testing - explores alternative statistical models

**Medium Priority (Subsequent):**
1. RQ 7.5.3 confidence-accuracy relationships - natural next step in Ch7 series
2. Sample size expansion planning - addresses fundamental power limitations
3. Cross-task validation design - compares VR vs traditional memory assessments

**Lower Priority (Aspirational):**
1. Longitudinal mood-memory study - ideal but requires major resource commitment
2. Clinical sample recruitment - valuable but beyond current thesis scope
3. Neuroimaging integration - interesting but outside current methodological focus

### Next Steps Summary

The null DASS-memory findings raise three critical questions requiring immediate investigation:

1. **Domain Masking:** Does omnibus theta_all aggregate mask domain-specific effects? (High priority)
2. **Clinical Thresholds:** Do effects emerge only at clinical DASS levels? (High priority)  
3. **Non-Linear Patterns:** Are linear models misspecified for mood-memory relationships? (High priority)

Methodological extensions addressing power limitations are valuable but require resources beyond current thesis scope. Focus should remain on maximizing insights from available data before expanding to new samples.

---

**Summary generated by:** rq_results agent (v4.0)
**Pipeline version:** v4.X (13-agent atomic architecture)  
**Date:** 2026-01-06T15:30:00Z